GlassScriptPhysician profile
Michael Clouatre
NPI 1497756415
$2,834.80
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $445 · 2021: $946 · 2022: $570 · 2023: $432 · 2024: $79.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.20 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,336.93 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $282.26 | 2022-2023 | Veozah |
| Mayne Pharma Commercial LLC | $232.27 | 2021-2023 | |
| Pfizer INC. | $220.39 | 2020-2024 | |
| Ethicon US, LLC | $122.28 | 2019-2021 | |
| Exeltis, USA INC. | $117.29 | 2020-2024 | Slynd |
| Hologic Sales and Service, LLC | $91.37 | 2019-2024 | Aptima, Novasure, Coolseal Generator |
| Organon LLC | $86.06 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $74.41 | 2019-2023 | |
| Mylan Pharmaceuticals INC. | $30.81 | 2021-2022 | |
| Boston Scientific Corporation | $30.17 | 2019 | |
| Therapeuticsmd, INC. | $29.55 | 2019 | |
| Allergan, INC. | $26.36 | 2019-2020 | |
| Avion Pharmaceuticals | $26.30 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $24.70 | 2024 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $22.39 | 2021 | |
| Meditrina | $15.08 | 2022 | |
| Merck Sharp & Dohme LLC | $15.00 | 2021 | |
| Coopersurgical, INC. | $14.56 | 2019 | |
| Myovant Sciences INC. | $12.94 | 2022 | |
| Channel Medsystems, INC. | $12.03 | 2023 | |
| Amag Pharmaceuticals, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clouatre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.